Drug–Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection

被引:0
|
作者
Hala Mohsen Abdullatif
Rania Ramzi
Engy Adel Mogahed
Carolyne Morcos Ghobrial
Basma Abd El Rasheed Abd El Zaher
Mona S. El Raziky
Hanaa Mostafa El-Karaksy
机构
[1] Cairo University Pediatric Hospital,Pediatric Hepatology Unit
[2] Kasr Alainy Drug Information Center,undefined
[3] Cairo University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:857 / 864
页数:7
相关论文
共 50 条
  • [31] Severe Myositis With the Use of Sofosbuvir/Ledipasvir for Hepatitis C Infection: A Case of Unexpected Interactions
    Patel, Shyam
    Trakroo, Sushrut
    Sanaka, Sirish
    Qureshi, Kamran
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S333 - S333
  • [32] Ledipasvir and sofosbuvir:Interferon free therapy for hepatitis C virus genotype 1 infection
    Yasir Waheed
    World Journal of Virology, 2015, (01) : 33 - 35
  • [33] Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis C
    Cuenca-Lopez, Francisca
    Rivero, Antonio
    Rivero-Juarez, Antonio
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (01) : 105 - 112
  • [34] Treatment of Hepatitis C with Sofosbuvir/Ledipasvir in Elderly Veterans
    Blanquicett, C. J.
    Mirk, A.
    Cartwright, E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S100 - S100
  • [35] Drug Interactions in the Treatment of Hepatitis C Virus Infection - still relevant for clinical Practice?
    Schulte, Benjamin
    Wuebbolding, Maximilian
    Port, Kerstin
    Back, David
    Marra, Fiona
    Manns, Michael P.
    Cornberg, Markus
    Maasoumy, Benjamin
    zu Siederdissen, Christoph Hoener
    INTERNIST, 2019, 60 : S27 - S27
  • [36] Treatment of Patients with Hepatitis C Virus infection (Genotype 4) with Ledipasvir-Sofosbuvir in the liver transplant setting
    Abaalkhail, Faisal A.
    Elsiesy, Hussein A.
    Al Sebayel, Mohammed
    Aljedai, Ahmed
    Ajlan, Aziza A.
    Elbeshbeshy, Hany
    Al-Hamoudi, Waleed K.
    HEPATOLOGY, 2016, 64 : 956A - 957A
  • [37] SOFOSBUVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION
    Temesgen, Z.
    Talwani, R.
    Rizza, S. A.
    DRUGS OF TODAY, 2014, 50 (06) : 421 - 434
  • [38] Development of sofosbuvir for the treatment of hepatitis C virus infection
    Lawitz, Eric
    Jacobson, Ira M.
    Nelson, David R.
    Zeuzem, Stefan
    Sulkowski, Mark S.
    Esteban, Rafael
    Brainard, Diana
    McNally, John
    Symonds, William T.
    McHutchison, John G.
    Dieterich, Douglas
    Gane, Edward
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN 2014, 2015, 1358 : 56 - 67
  • [39] Ledipasvir-sofosbuvir for hepatitis C genotype 4 infection
    Smith, Michael A.
    Mohammad, Rima A.
    LANCET INFECTIOUS DISEASES, 2015, 15 (09): : 993 - 995
  • [40] No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection
    Sulkowski, Mark S.
    Chuang, Wan-Long
    Kao, Jia-Horng
    Yang, Jenny C.
    Gao, Bing
    Brainard, Diana M.
    Han, Kwang-Hyub
    Gane, Edward
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (09) : 1202 - 1204